Eric Mark Green
Known title: President & CEOCIK: 0001336007
Eric Mark Green's purchase track record
Eric Mark Green has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/11/2026 | ECL | $1.02M | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
West Pharmaceutical Services noted in analyst upgrade and market rally. West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.
Transaction History
| ECL | ▲ Buy | Open Market | 3,370 | $932K | 9/11/2026 | View on chart |
| ECL | ▲ Buy | Open Market | 320 | $89K | 9/11/2026 | View on chart |
| ECL | ▲ Buy | Grant | 130 | $0 | 6/30/2026 | View on chart |
| ECL | ▲ Buy | Grant | 144 | $40K | 6/30/2026 | View on chart |
| ECL | ▲ Buy | Grant | 138 | $0 | 3/31/2026 | View on chart |
| ECL | ▲ Buy | Grant | 152 | $40K | 3/31/2026 | View on chart |
| WST | ▲ Buy | Option Exercise | 1,319 | — | 2/18/2026 | View on chart |
| WST | ▼ Sell | Tax Withholding | 574 | $142K | 2/18/2026 | View on chart |
| WST | ▼ Sell | Tax Withholding | 1,305 | $317K | 2/17/2026 | View on chart |
| WST | ▲ Buy | Grant | 4,419 | $0 | 2/17/2026 | View on chart |
| ECL | ▲ Buy | Grant | 128 | $0 | 12/31/2025 | View on chart |
| ECL | ▲ Buy | Grant | 137 | $36K | 12/31/2025 | View on chart |
| ECL | ▲ Buy | Grant | 123 | $0 | 9/30/2025 | View on chart |
| ECL | ▲ Buy | Grant | 132 | $36K | 9/30/2025 | View on chart |
| ECL | ▲ Buy | Grant | 126 | $0 | 6/30/2025 | View on chart |
| ECL | ▲ Buy | Grant | 136 | $36K | 6/30/2025 | View on chart |
| ECL | ▲ Buy | Grant | 134 | $0 | 3/31/2025 | View on chart |
| ECL | ▲ Buy | Grant | 144 | $36K | 3/31/2025 | View on chart |
| WST | ▲ Buy | Option Exercise | 2,461 | $519K | 2/18/2025 | View on chart |
| WST | ▼ Sell | Tax Withholding | 700 | $148K | 2/18/2025 | View on chart |
| ECL | ▲ Buy | Grant | 144 | $0 | 12/31/2024 | View on chart |
| ECL | ▲ Buy | Grant | 154 | $36K | 12/31/2024 | View on chart |
| ECL | ▲ Buy | Grant | 133 | $0 | 9/30/2024 | View on chart |
| ECL | ▲ Buy | Grant | 143 | $36K | 9/30/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 30,732 | $1.8M | 8/6/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 6,000 | $358K | 8/6/2024 | View on chart |
| WST | ▼ Sell | Open Market | 30,732 | $9.4M | 8/6/2024 | View on chart |
| ECL | ▲ Buy | Grant | 144 | $34K | 6/30/2024 | View on chart |
| ECL | ▲ Buy | Grant | 141 | $0 | 6/30/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 9,316 | $535K | 5/7/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 15,684 | $900K | 5/7/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 41,000 | $2.4M | 5/7/2024 | View on chart |
| WST | ▼ Sell | Open Market | 9,316 | $3.4M | 5/7/2024 | View on chart |
| WST | ▼ Sell | Open Market | 15,684 | $5.8M | 5/7/2024 | View on chart |
| WST | ▼ Sell | Open Market | 41,000 | $15.0M | 5/7/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 9,000 | $537K | 5/7/2024 | View on chart |
| ECL | ▲ Buy | Grant | 135 | $31K | 3/31/2024 | View on chart |
| ECL | ▲ Buy | Grant | 146 | $0 | 3/31/2024 | View on chart |
| WST | ▼ Sell | Open Market | 64,132 | $23.1M | 2/27/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 9,000 | $516K | 2/27/2024 | View on chart |
| WST | ▲ Buy | Option Exercise | 64,132 | $3.7M | 2/27/2024 | View on chart |
| WST | ▲ Buy | Grant | 6,567 | $0 | 2/20/2024 | View on chart |
| ECL | ▲ Buy | Grant | 151 | $30K | 12/31/2023 | View on chart |
| ECL | ▲ Buy | Grant | 157 | $0 | 12/31/2023 | View on chart |
| WST | ▼ Sell | Gift | 9,800 | $3.4M | 12/6/2023 | View on chart |
| ECL | ▲ Buy | Grant | 176 | $30K | 9/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 184 | $0 | 9/30/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 50,000 | $2.9M | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 1,000 | $390K | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 4,500 | $1.8M | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 7,684 | $3.0M | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 1,100 | $438K | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 7,055 | $2.8M | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 8,329 | $3.3M | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 6,700 | $2.7M | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 100 | $40K | 8/8/2023 | View on chart |
| WST | ▼ Sell | Open Market | 7,532 | $3.0M | 8/8/2023 | View on chart |
| ECL | ▲ Buy | Grant | 168 | $0 | 6/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 161 | $30K | 6/30/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 50,000 | $2.9M | 5/9/2023 | View on chart |
| WST | ▼ Sell | Open Market | 14,157 | $5.1M | 5/9/2023 | View on chart |
| WST | ▼ Sell | Open Market | 12,562 | $4.6M | 5/9/2023 | View on chart |
| WST | ▼ Sell | Open Market | 12,648 | $4.6M | 5/9/2023 | View on chart |
| WST | ▼ Sell | Open Market | 4,133 | $1.5M | 5/9/2023 | View on chart |
| WST | ▼ Sell | Open Market | 500 | $183K | 5/9/2023 | View on chart |
| ECL | ▲ Buy | Grant | 182 | $30K | 3/31/2023 | View on chart |
| ECL | ▲ Buy | Grant | 190 | $0 | 3/31/2023 | View on chart |
| WST | ▲ Buy | Option Exercise | 50,000 | $2.9M | 3/7/2023 | View on chart |
| WST | ▼ Sell | Open Market | 5,277 | $1.7M | 3/7/2023 | View on chart |
| WST | ▼ Sell | Open Market | 7,685 | $2.5M | 3/7/2023 | View on chart |
| WST | ▼ Sell | Open Market | 26,753 | $8.6M | 3/7/2023 | View on chart |
| WST | ▼ Sell | Open Market | 3,154 | $1.0M | 3/7/2023 | View on chart |
| WST | ▼ Sell | Open Market | 1,131 | $367K | 3/7/2023 | View on chart |
| WST | ▲ Buy | Grant | 14,783 | $4.5M | 2/21/2023 | View on chart |
| ECL | ▲ Buy | Grant | 56 | $0 | 12/31/2022 | View on chart |
| WST | ▲ Buy | Option Exercise | 50,000 | $2.9M | 12/5/2022 | View on chart |
| WST | ▼ Sell | Open Market | 6,746 | $1.6M | 12/5/2022 | View on chart |
| WST | ▼ Sell | Open Market | 9,408 | $2.2M | 12/5/2022 | View on chart |
| WST | ▼ Sell | Open Market | 9,682 | $2.3M | 12/5/2022 | View on chart |
| WST | ▼ Sell | Open Market | 6,312 | $1.5M | 12/5/2022 | View on chart |
| WST | ▼ Sell | Open Market | 10,752 | $2.6M | 12/5/2022 | View on chart |
| WST | ▼ Sell | Open Market | 1,100 | $266K | 12/5/2022 | View on chart |
| WST | ▲ Buy | Grant | 22,104 | $8.2M | 2/22/2022 | View on chart |
| WST | ▼ Sell | Tax Withholding | 85 | $33K | 2/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RBC and Citi highlight Ecolab's pricing power and specialty chemical strength
Recent analyst notes from RBC Capital Markets and Citi have focused on Ecolab's ability to maintain pricing and organic growth. These firms view the company as a defensive option that may benefit from a weaker dollar. The positive sentiment aligns with the stock trading near its 52-week high, reflecting strong investor interest in its stable earnings profile.
RBC and Citi highlight Ecolab's pricing power and specialty chemical strength. Recent analyst notes from RBC Capital Markets and Citi have focused on Ecolab's ability to maintain pricing and organic growth. These firms view the company as a defensive option that may benefit from a weaker dollar. The positive sentiment aligns with the stock trading near its 52-week high, reflecting strong investor interest in its stable earnings profile.